AngioWaveNet vs cmAngio®
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your cardiac catheterization laboratory requires AI-powered enhancement of fluoroscopic angiograms to improve real-time vessel visualization during interventional procedures. This tool is ideal for cath labs seeking to integrate advanced image processing seamlessly into existing workflows, regardless of their current angiography system vendor, to enhance diagnostic clarity and procedural guidance.
View AngioWaveNet →Choose cmAngio® if…
Choose cmAngio® if your radiology department aims to leverage existing mammography data for early cardiovascular risk assessment in women by detecting Breast Arterial Calcifications (BAC). This solution is best suited for facilities looking to provide additional insights into patient health without requiring extra radiation or procedures, utilizing both FFDM and DBT exams to identify and report BAC locations.
View cmAngio® →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | cmAngio® |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Paid, out-of-pocket |
| Deployment | Cloud-based or on-premise/servers | Cloud-based, integrates with any DICOM-compliant viewer |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AngioWaveNetAngioWaveNet emphasizes seamless integration with existing Cath lab workflows and is vendor-agnostic for angiography systems, suggesting broad compatibility and minimal disruption. While cmAngiou00ae boasts quick installation, AngioWaveNet's focus on deep workflow integration and system agnosticism provides a slight edge in overall usability within its specialized environment.
Clinical Value
AngioWaveNetAngioWaveNet directly enhances fluoroscopic angiograms, providing improved vessel visualization crucial for real-time decision-making during cardiac catheterization procedures. This immediate impact on image quality for critical interventions offers a more direct and immediate clinical utility compared to cmAngiou00ae's insights for long-term cardiovascular risk assessment.
Pricing & Value
AngioWaveNetAngioWaveNet offers transparent pricing models, including annual software licensing or subscription-based access tailored to cath lab volume and hospital needs. In contrast, cmAngiou00ae's pricing is not publicly available, requiring direct contact, which makes it harder for potential customers to assess initial value without engagement.
Enterprise Readiness
AngioWaveNetAngioWaveNet provides flexible deployment options, supporting both cloud-based and on-premise/server installations, which is critical for diverse enterprise IT infrastructures. Additionally, its vendor-agnostic compatibility with any fluoroscopic angiography system enhances its readiness for varied hospital environments.
Innovation
cmAngio®cmAngiou00ae demonstrates a higher degree of innovation by repurposing existing mammography data to detect Breast Arterial Calcifications, providing novel insights into cardiovascular health from a routine screening. This approach extracts new diagnostic information and bridges two distinct clinical areas, offering a transformative application of AI beyond image enhancement.
Support & Docs
TieNeither AngioWaveNet nor cmAngiou00ae provide specific details regarding their support services or documentation within the provided facts or readily available public information. As both are FDA-cleared medical software, a baseline level of support and documentation is expected, but no distinguishing factors are present to declare a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | cmAngio® |
|---|---|---|
| Name | AngioWaveNet | cmAngiou00ae |
| Company | Angiowave Imaging | CureMetrix |
| Description | FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows. | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. |
| Primary Application | Enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. | Detecting Breast Arterial Calcifications (BAC) on mammograms. |
| Key Feature 1 | AI-powered Spatiotemporal Enhancement Processing (STEPu2122) | AI-based detection of Breast Arterial Calcifications (BAC) |
| Key Feature 2 | Improved vessel visualization in fluoroscopic angiograms | Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and cmAngio®.